{
  "ptid_time": "012_S_4188_2015-10-08",
  "img_path": "/data/qiuhui/data/adni/images/012_S_4188/2015-10-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,315 mm³, 30.4% above the reference mean. With a Z-score of 0.88 (81.1th percentile), this represents normal volume ; hippocampal volume measures 5,611 mm³, 19.5% below the reference mean. With a Z-score of -1.68 (4.6th percentile), this represents moderate atrophy; whole brain volume measures 1,073,580 mm³, 4.3% above the reference mean. With a Z-score of 0.57 (71.4th percentile), this represents normal volume ; entorhinal cortex volume measures 1,914 mm³, 51.8% below the reference mean. With a Z-score of -3.39 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 16,167 mm³, 10.5% below the reference mean. With a Z-score of -0.91 (18.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,613 mm³, 2.8% below the reference mean. With a Z-score of -0.25 (40.2th percentile), this represents normal volume . ",
  "text_data": "Age is 81.2 years. Gender is Male. Education: 14 years. MMSE: 21.0. MoCA: 12.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.42 SUVR (significant elevated); Amyloid beta: 567.50 pg/mL (mild reduced); Total tau: 341.90 pg/mL (mild elevated); Phosphorylated tau: 32.42 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows **moderate hippocampal atrophy (Z-score -1.68, 4.6th percentile)** and **profound entorhinal cortex atrophy (Z-score -3.39, 0.0th percentile)**, both strongly associated with Alzheimer's pathology. The **MMSE (21) and MoCA (12)** indicate cognitive impairment, and biomarker findings (**elevated AV45, mild Aβ reduction, and elevated tau**) support Alzheimer's pathophysiology.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key supporting factors: severe entorhinal/hippocampal atrophy, low MoCA, amyloid/tau biomarkers, and age-consistent AD risk.)*",
  "timestamp": "2025-07-25T23:13:58.108643"
}